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Abstract
Background: Enterotoxigenic Escherichia coli (ETEC) infections result in large economic losses in the swine industry
worldwide. ETEC infections cause pro-inflammatory responses in intestinal epithelial cells and subsequent diarrhea in pigs,
leading to reduced growth rate and mortality. Administration of probiotics as feed additives displayed health benefits
against intestinal infections. Saccharomyces cerevisiae (Sc) is non-commensal and non-pathogenic yeast used as probiotic in
gastrointestinal diseases. However, the immuno-modulatory effects of Sc in differentiated porcine intestinal epithelial cells
exposed to ETEC were not investigated.
Methodology/Principal Findings: We reported that the yeast Sc (strain CNCM I-3856) modulates transcript and protein
expressions involved in inflammation, recruitment and activation of immune cells in differentiated porcine intestinal
epithelial IPEC-1 cells. We demonstrated that viable Sc inhibits the ETEC-induced expression of pro-inflammatory transcripts
(IL-6, IL-8, CCL20, CXCL2, CXCL10) and proteins (IL-6, IL-8). This inhibition was associated to a decrease of ERK1/2 and p38
MAPK phosphorylation, an agglutination of ETEC by Sc and an increase of the anti-inflammatory PPAR-c nuclear receptor
mRNA level. In addition, Sc up-regulates the mRNA levels of both IL-12p35 and CCL25. However, measurement of
transepithelial electrical resistance displayed that Sc failed to maintain the barrier integrity in monolayer exposed to ETEC
suggesting that Sc does not inhibit ETEC enterotoxin activity.
Conclusions: Sc (strain CNCM I-3856) displays multiple immuno-modulatory effects at the molecular level in IPEC-1 cells
suggesting that Sc may influence intestinal inflammatory reaction.
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Introduction
Enterotoxigenic Escherichia coli (ETEC) is a major cause of
intestinal infection in piglets inducing diarrhea, reduced growth
rate and mortality leading to economic loss [1]. Pathogeny of
ETEC is characterized by its adhesion to the intestinal epithelial
cells (IEC) through adhesins which interact with their specific
receptors localized on the brush border membrane [2,3,4].
Following jejunal and ileal mucosa colonization, ETEC strains
secrete several enterotoxins, including the heat-labile enterotoxin
(LT), the heat-stable enterotoxin (STa and/or STb), and the
enteroaggregative E. coli heat-stable enterotoxin 1 (EAST1) [5,6].
These enterotoxins cause perturbation of hydroelectrolytic secre-
tions in the small intestine resulting in diarrhea [5].
ETEC strains expressing the F4 fimbriae are involved in neonatal
and post-weaning diarrhea [1]. ETEC F4
+ infections mainly occur
during the first week after weaning in piglets expressing the F4
receptor on the intestinal brush border [7]. The weaning-related
stress, the dietarychanges and theimmaturityoftheimmunesystem
are several factors contributing to the disease severity [1]. ETEC
F4
+ strains represent the most prevalent form of bacterial infection
in piglets [1,8] and an increase in incidence of ETEC-associated
diarrhea was observed worldwide [1]. Furthermore, antibiotic
growth promoters were prohibited in the European Union since
2006 (IP/05/1687) and antibiotic-multiresistant ETEC isolates
have been identified [9,10,11]. Consequently, new prophylactic
and/or therapeutic strategies should be developed to protect piglets
from ETEC infection. The interest in using probiotic microorgan-
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animals has increased significantly in the last decade worldwide.
Saccharomyces cerevisiae variety boulardii (Sb) has been shown to provide
intestinal protection against various enteric pathogens [12]. Indeed,
Sb protected the host through multiple mechanisms such as
inhibition of pathogen adhesion [13], neutralization of bacterial
virulence factors [14], maintenance of epithelial barrier integrity
[15], decrease of pathogen-associated inflammation [16] and
stimulation of the immune system [17]. Regarding Sb effects on
pathogen-associated inflammation, this yeast has been shown to
modulate pro-inflammatory signaling pathways leading to the
inhibitionofmitogen-activated proteinkinases(MAPK)andnuclear
factor NF-kB activition in IEC [16,18]. Because IEC play a key role
in regulating innate and adaptive immune responses of the gut [19],
several studies have evaluated yeast probiotic effects on these cells
[15,16,18,20,21,22,23]. Epithelial cells protect the intestine through
different mechanisms such as barrier function, mucus secretion,
antibacterial peptide synthesis, cytokine and chemokine secretions
[19]. IEC detect pathogen-associated molecular patterns (PAMPs)
through their pathogen recognition receptors (PRR) and then
secrete cytokines and chemokines that activate pro-inflammatory
signaling pathways and direct the migration of various effector cells
involved in innate and adaptive immunity [24]. However,
inflammatory responses induced by enteric pathogens can lead to
dysregulation of IEC signaling, disruption of membrane barrier
integrity, enhancement of pathogen translocation and disease [25].
With their pivotal role in the gut homeostasis, IEC are particularly
relevant to assess yeast immuno-regulatory effects.
Saccharomyces cerevisiae (Sc) is non-commensal and non-pathogenic
yeast used in food industry as brewer and baker’s yeast. Sc and Sb
are members of the same yeast species [26] but they present some
genetical, metabolical and physiological differences [27,28]. Sc
(strain CNCM I-3856) is a probiotic yeast studied for its beneficial
effects on animal growth, host immune function and inhibition of
Salmonella spp. adhesion [29,30]. Furthermore, Sc (strain CNCM I-
3856) has been shown to decrease inflammation in a mouse model
of chemically-induced colitis [31], to reduce digestive discomfort
and abdominal pain in IBS patients [32] and to exert in vitro
antagonist effect against E. coli O157:H7 [33]. In the current
study, we use an in vitro model of differentiated porcine intestinal
epithelial IPEC-1 cells co-cultured with Sc (strain CNCM I-3856)
and F4
+ ETEC (strain GIS26). IPEC-1 cells provide a relevant
model since F4
+ ETEC has been shown to bind IPEC-1 cells
which express cytokines and chemokines after ETEC stimulation
[34,35]. In addition, the ETEC strain GIS26 has been shown to
infect newly weaned piglets (Verdonck et al. 2002). Few data are
available regarding yeast immuno-modulatory effects in porcine
IEC exposed to ETEC. These data showed that Sc and Sb
inhibited IL-1a transcript expression in non-differentiated IPEC-
J2 cell line [36]. Consequently, using differentiated IPEC-1 cells,
we investigated in this report whether Sc modulates gene
expressions and signaling pathways involved in inflammation,
recruitment and activation of immune cells. Then, we assessed
whether Sc could prevent the disruption of the membrane barrier
integrity induced by ETEC.
Results
Saccharomyces cerevisiae (strain CNCM I-3856) and ETEC
(strain GIS26) modulate differently immune gene
expression in differentiated IPEC-1 cells
In this work, we aimed to compare the effects of Sc and ETEC
on IPEC-1 gene expressions involved in inflammation, innate
and adaptive immunity. As illustrated by scanning electron
microscopy, differentiated IPEC-1 cells displayed microvilli and
both Sc and ETEC interact with these cells (Figure 1).
Characterization of Sc and ETEC immuno-modulatory effects
was first assessed by analysis of transcript expressions. The
analysed genes are presented in Table 1. ETEC increased
significantly the mRNA expression (p,0.01) of the pro-
inflammatory cytokines TNF-a (x 3075.6), IL1-a (x 46.9), IL-6
(x 7.8), the pro-Th2 cytokine IL-5 (x 2.6), and the chemokines
CCL20 (x 5726.1), CXCL2 (x 857.4), IL-8 (x 670.2), CXCL10 (x
7.1) and CXCL12 (x 3) (Table 2). In contrast, Sc did not
significantly up-regulate these transcripts but increased the
expression (p,0.01) of the pro-Th1 cytokine IL-12p35 (x 10.7),
the chemokine CCL25 (x 2.7), the anti-inflammatory nuclear
receptor PPAR-c (x 2.6), the mucine MUC1 (x 2.21) and
decreased the mRNA expression of the pro-Th2 cytokine BAFF
(4 2.5, p,0.01) (Table 2). Thus, this result shows that Sc and
ETEC display different modulatory effects on transcripts
involved in both inflammatory and immune responses.
Figure 1. Interaction of Saccharomyces cerevisiae or ETEC with differentiated IPEC-1 cells. Differentiated IPEC-1 cells were cultured
overnight with Sc (3610
6 yeasts/well) or exposed to ETEC (3610
7 CFU/well) for 45 min. IPEC-1 cells were then assessed to scanning electron
microscopy. (A) Differentiated IPEC-1 cells expressed microvilli on their surface, (B) Sc interacts with differentiated IPEC-1 cells, (C) ETEC interacts with
differentiated IPEC-1 cells.
doi:10.1371/journal.pone.0018573.g001
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Primer name Primer sequence
Annealing temperature(s)
(6C) PCR product (bp) Accession number or reference
APRIL/TNFSF13 S: TGCTCACCCGTAAACAGAAG
AS: TAAACTCCAGCATCCCAGAC
60 172 Meurens et al., 2009
BAFF/TNFSF13B S: GAGAGCAGCTCCATTCAAAG
AS: GCATGCCACTGTCTGCAATC
60 103 Meurens et al., 2009
CCL2/MCP-1 S: GTCACCAGCAGCAAGTGTC
AS: CCAGGTGGCTTATGGAGTC
60 112 Meurens et al., 2009
CCL17/TARC S: TGCTGCTCCTGGTTGCTCTC
AS: ATGGCGTCCCTGGTACACTC
67 169 Bruel et al.,2 0 0 9
CCL20/MIP3 alpha S: GCTCCTGGCTGCTTTGATGTC
AS: CATTGGCGAGCTGCTGTGTG
66 146 Meurens et al., 2009
CCL22/MDC S: GTCCTCCTTGCTGTGATAC
AS: CTCGGTCCCTCAAGGTTAG
60 184 DB798783
CCL25/TECK S: ACCTGCCTGCTGTGATATTC
AS: TCCGATTGTCCAGGATCTTC
62 105 NM_001025214
Cdx-1 S: ACAGCCGCTATATCACCATC
AS: GTTCACTTTGCGCTCCTTTG
60 116 ENSFM00600000921619 http://
ensembl.org
Cdx-2 S: CAGTCGCTACATCACCATTC
AS: GCTGTTGCTGCAACTTCTTC
60 137 GU_17420
CXCL2/GRO beta S: TGCTGCTCCTGCTTCTAGTG
AS: TGGCTATGACTTCCGTTTGG
60 171 Meurens et al., 2009
CXCL10/IP-10 S: CCCACATGTTGAGATCATTGC AS:
CATCCTTATCAGTAGTGCCG
60 168 Meurens et al., 2009
CXCL12/SDF-1 S: TGCCTCAGCGATGAGAAAC
AS: GGGTCAATGCACACTTGTC
58 173 AY312066
HMBS2 S: AGGATGGGCAACTCTACCTG
AS: GATGGTGGCCTGCATAGTCT
58 83 Nygard et al.,2 0 0 7
HPRT-1 S: GGACTTGAATCATGTTTGTG
AS: CAGATGTTTCCAAACTCAAC
60 91 Nygard et al.,2 0 0 7
IFN gamma A: GCTCTGGGAAACTGAATGAC
AS: TCTCTGGCCTTGGAACATAG
60 167 Meurens et al., 2009
IL-1 alpha/LAF S: CCCGTCAGGTCAATACCTC
AS: GCAACACGGGTTCGTCTTC
60 170 NM_214029
IL-4/BCGF S: CAACCCTGGTCTGCTTACTG
AS: CTTCTCCGTCGTGTTCTCTG
65 173 Meurens et al., 2009
IL-5/EDF S: TGGAGCTGCCTACGTTAGTG
AS: TCGCCTATCAGCAGAGTTCG
64 105 Meurens et al., 2009
IL-6/IFN beta 2 S: ATCAGGAGACCTGCTTGATG
AS: TGGTGGCTTTGTCTGGATTC
62 177 Meurens et al., 2009
IL-8/CXCL-8 S: TCCTGCTTTCTGCAGCTCTC
AS: GGGTGGAAAGGTGTGGAATG
62 100 Meurens et al., 2009
IL-10/B-TCGF S: GGTTGCCAAGCCTTGTCAG
AS: AGGCACTCTTCACCTCCTC
60 202 NM_214041
IL-12p35 S: GGCCTGCTTACCACTTGAAC
AS: GCATTCATGGCCTGGAACTC
64 180 Meurens et al., 2009
IL-13 A: TGGCGCTCTGGTTGACTCTG
AS: CCATGCTGCCGTTGCATAGG
67 159 Meurens et al., 2009
IL-17A/CTLA-8 A: CCAGACGGCCCTCAGATTAC
AS: CACTTGGCCTCCCAGATCAC
66 103 Meurens et al., 2009
IL-23p19 S: CTCCTTCTCCGCCTCAAGATCC
AS:TTGCTGCTCCATGGGCGAAGAC
70 82 Meurens et al., 2009
IL-33 S: AGCTTCGCTCTGGCCTTATC
AS: GCTGACAGGCAGCAAGTACC
63 126 Meurens et al., 2009
MUC1 S: TAAAGAAGACGGGCTTCTGG
AS: CCGCTTTAAGCCGATCAAAC
60 134 XM_001926883
MUC2 S: ACCCGCACTACGTCACCTTC
AS: GGCAGGACACCTGGTCATTG
62 150 Bruel et al.,2 0 0 9
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transcript expression in differentiated IPEC-1 cells
Overnight pre-incubation of IPEC-1 cells with viable Sc before
ETEC exposure for 3 h inhibited significantly CCL20 (4 10.7),
CXCL10 (4 6), IL-6 (4 5), IL-8 (4 2.3), and CXCL2 (4 2.2)
mRNA expressions (p,0.01) (Figure 2.A). In contrast, Sc did not
decrease significantly the mRNA expressions of TNF-a, IL-1a, IL-
5 and CXCL12 which were up-regulated by ETEC. In addition,
Sc inhibitory effect on BAFF mRNA expression was not conserved
in presence of ETEC (data not shown). However, when Sc was
killed, no inhibitory effects were observed suggesting that yeast-
secreted factors are essential to inhibit the ETEC-induced gene
expressions (Figure 2.B). Regarding Sc stimulatory effects,
overnight pre-incubation of IPEC-1 cells with viable yeasts still
up-regulated IL-12p35, CCL25 and PPAR-c mRNA expressions
(p,0.05) in IPEC-1 cells exposed to ETEC for 3 h (respectively x
8.9, x 3.1 and x 2.2) (Figure 3.A). The MUC1 mRNA was still up-
regulated in presence of ETEC as observed with Sc alone (x 2.0,
p,0.01, data not shown). However, when the yeast was killed, no
stimulatory effects were observed in presence of ETEC and only
IPEC-1 cells cultured with killed Sc alone showed this pattern of
up-regulated mRNA expression (Figure 3.B). Because Sc up-
regulated CCL25 mRNA levels, we also analysed whether IPEC-1
cells expressed the homeobox transcription factors Cdx-1 and -2,
which are involved in CCL25 transcription. Analysis displayed
that in these conditions of co-culture, Cdx-1 and -2 mRNA were
not expressed in differentiated IPEC-1 cells (data not shown).
Saccharomyces cerevisiae decreases the ETEC-induced
IL-6 and IL-8 secretions in differentiated IPEC-1 cells
At the protein level, overnight pre-incubation of IPEC-1 cells
with viable or killed Sc did not modify apical IL-6 and IL-8
secretions in comparison to untreated cells (Figure 4.A, 4.B)
whereas exposure with ETEC for 30 min up-regulated signifi-
cantly the secretion of IL-6 (49.2961.32 versus 36.0662.21 pg/
mL, p,0.05) and IL-8 (720650.87 versus 335.86105.8 pg/mL,
p,0.05) (Figure 4.A, 4.B). In contrast, neither Sc nor ETEC
induced the basolateral secretion of IL-6 and IL-8. The basolateral
concentration of these cytokines was below the detection threshold
of ELISA kits (data not shown). Overnight pre-incubation of
IPEC-1 cells with viable Sc before ETEC exposure for 30 min
inhibited significantly the apical secretions of IL-6 (36.2163.10
versus 49.2961.32 pg/mL, p,0.01) and IL-8 (300692.21 versus
720650.87 pg/mL, p,0.05) (Figure 4.A, 4.B). However, killed Sc
did not inhibit significantly the ETEC-induced apical secretions of
IL-6 and IL-8 (Figure 4.A, 4.B). These results are in accordance
with those observed for the modulation of IL-6 and IL-8
transcripts indicating that Sc display anti-inflammatory properties
at the molecular level.
Saccharomyces cerevisiae decreases ERK1/2 and p38
MAPK phosphorylation in differentiated IPEC-1 cells
We next examined the effect of Sc on the activation of different
protein kinases which are involved in pro-inflammatory gene
expressions. Thus, we analysed Sc modulatory effects on MAPK
(ERK1/2, p38, JNK), Akt and AMP-activated protein kinase
(AMPK) phosphorylation using phospho-specific antibodies. As
shown in Figure 5, Sc decreases the phosphorylation of ERK1/2
and p38. In control cells, the phosphorylated active-forms of
ERK1/2 and p38 are detectable. Cells pre-incubated with Sc
alone showed a significant decrease in p38 phosphorylation
(p,0.05) but not in ERK1/2 (Figure 5). In contrast, ETEC
exposure for 30 min enhanced the phosphorylation level of
ERK1/2 (p,0.05) and ETEC exposure for 60 min enhanced
the phosphorylation of p38 (p=0.06) (Figure 5). When IPEC-1
cells were pre-incubated with Sc and then infected with ETEC, the
active form of ERK1/2 was reduced at the level of control cells
(p,0.05) whereas the active form of p38 was lower than control
cells (p,0.05) (Figure 5). No effect was observed on Akt and
AMPK activation, and JNK detection level was too low to display
any regulatory effect of Sc (data not shown). These results indicated
that Sc inhibitory effects on cytokine and chemokine mRNA
Primer name Primer sequence
Annealing temperature(s)
(6C) PCR product (bp) Accession number or reference
MUC4 S: CTGCTCTTGGGCACTATATG
AS: CCTGTGACTGCAGAATCAAC
60 133 DQ848681
PBD-1 S: ACCGCCTCCTCCTTGTATTC
AS: CACAGGTGCCGATCTGTTTC
62 150 Meurens et al.,2 0 0 9
PBD-2 S: TTGCTGCTGCTGACTGTCTG
AS: CTTGGCCTTGCCACTGTAAC
62 180 Meurens et al.,2 0 0 9
PPAR gamma S: AAGACGGGGTCCTCATCTCC
AS: CGCCAGGTCGCTGTCATCT
62 149 Bassaganya-Riera et al., 2006
RPL-19 S: AACTCCCGTCAGCAGATCC
AS: AGTACCCTTCCGCTTACCG
60 147 Meurens et al.,2 0 0 9
Secretory component S: ACTGGTGTCGCTGGGAAGAG
AS: GACCGTGAAGGTGCCATTGC
64 131 CJ025705
TGF beta S: GAAGCGCATCGAGGCCATTC
AS: GGCTCCGGTTCGACACTTTC
64 162 Meurens et al.,2 0 0 9
TNF alpha/TNFSF2 S: CCAATGGCAGAGTGGGTATG
AS: TGAAGAGGACCTGGGAGTAG
62 116 Meurens et al.,2 0 0 9
TSLP S: AGGGCTTGTGCTAACCTAC
AS: ATCCGGCCTATCATCACAG
58 164 Meurens et al.,2 0 0 9
Reference genes are underlined.
doi:10.1371/journal.pone.0018573.t001
Table 1. Cont.
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phosphorylation in IPEC-1 cells.
Saccharomyces cerevisiae agglutinates ETEC
We investigated whether Sc modulates ETEC growth and
adhesion on IPEC-1 cells. Overnight pre-incubation of IPEC-1 cells
with Sc before ETEC exposure increased the number of cell-
associated ETEC (8.0262.31610
5 CFU/wells in ETEC group versus
32.0861.33610
5 CFU/wells in Sc+ETEC group) and decreased the
number of non cell-associated ETEC (4.9560.34610
8 CFU/wellsin
ETEC group versus 2.260.29610
8 CFU/wells in Sc+ETEC group)
(Fig. 6.A, 6.B). Consequently, we assessed whether adherent yeasts on
IPEC-1 cells could interact with ETEC thus forming agglutinates on
the surface monolayer. Scanning electron microscopy of IPEC-1 cells
exposed with ETEC did not demonstrate ETEC agglutination by Sc
on the surface monolayer. In contrast, a physical interaction between
yeasts and ETEC isolated from IPEC-1 cells culture supernatant was
observed by phase-contrast microscopy (Fig. 6.C).
Saccharomyces cerevisiae did not prevent the disruption
of membrane barrier integrity induced by ETEC
To assess the protective effect of Sc on the monolayer barrier
function, transepithelial electrical resistance (TER) was measured
in IPEC-1 cells pre-incubated or not with Sc and then exposed to
ETEC for 3 h. Overnight pre-incubation of IPEC-1 cells with Sc
alone did not alter the monolayer resistance (TER.8000
ohm.cm
2) (Figure 7). In contrast, when IPEC-1 cells were exposed
to ETEC, a significant TER decrease was already observed at 1 h
of exposure (3934650 ohm.cm
2, p,0.001) (Figure 7). Overnight
pre-incubation of IPEC-1 cells with Sc before ETEC exposure did
not preserve the barrier function in comparison to both untreated
and Sc-treated cells, thus resulting in a significant TER decrease
after 1 h of ETEC exposure (19156246 ohm.cm
2, p,0.001)
(Figure 7). In presence of Sc, despite a higher TER drop at 1 h of
ETEC exposure, no differences were observed at 2 h and 3 h in
comparison to monolayers exposed with ETEC alone (Figure 7).
Discussion
In pigs, enterotoxigenic Escherichia coli (ETEC) is the most
common etiologic agent of enteric diseases in the weaning period
[1]. ETEC infection induces pro-inflammatory responses in
porcine intestinal epithelial cells [37] and causes diarrhea resulting
in reduced growth rate, mortality and economic loss [1,5]. Since
2006, administration of antibiotics as growth promoters in the
piglet diet was prohibited in the European Union (IP/05/1687)
and consequently, alternative strategies such as probiotics were
developed to prevent intestinal diseases and to maintain health
status [38,39].
In this study, we investigated Saccharomyces cerevisiae (Sc, strain
CNCM I-3856) modulatory effects on the expression of genes
involved in inflammation, recruitment and activation of immune
cells. IEC represent a relevant model to study yeast probiotic
effects in the intestinal tract because IEC are involved in several
mechanisms allowing protection such as barrier function, mucus
layer protection, antibacterial peptide secretion and cytokine and
chemokine secretion [19]. Consequently, IEC are involved in
innate immunity as well as in the induction of adaptive immunity
at the mucosal surface. In this study, we used as model of IEC the
porcine IPEC-1 cell line exposed to ETEC. Previous reports
suggest the presence of F4 receptor onto the apical surface of
IPEC-1 cells since ETEC F4
+ can adhere to these cells [34,35]. In
addition, IPEC-1 exposure to ETEC F4
+ stimulate pro-inflam-
matory responses in IEC [35,37]. Moreover, bacterial constituents
like flagellin and lipopolysaccharide have been shown to activate
MAPK signaling pathways in IEC [40,41]. In the current work,
we showed that only viable Sc decreased the ETEC-induced
mRNA expressions of pro-inflammatory IL-6, IL-8, CCL20,
CXCL2 and CXCL10. In addition, viable Sc decreased the apical
secretions of IL-6 and IL-8 whereas no secretions were observed at
the basolateral level. This result indicates a polarization of IL-6
and IL-8 secretions as described previously in both polarized
epithelial and endothelial cells [42,43,44]. Taken together, these
results indicate that Sc viability is essential and confirm the
presence and the action of a soluble secreted factor as
demonstrated in previous studies [45,46]. In addition, a recent
Table 2. Effects of Saccharomyces cerevisiae or ETEC on
transcript expressions in IPEC-1 cells (fold changes in
comparison to controls).
Transcripts Expression level S. cerevisiae ETEC
APRIL moderate 0.60 1.13
BAFF low 0.40 ** 0.74
CCL2 moderate 1.32 6.83
CCL17 not detected - -
CCL20 moderate 3.61 5726.08 **
CCL22 not detected - -
CCL25 moderate 2.73** 1.11
CXCL2 moderate 1.65 857.44 **
CXCL10 moderate 1.18 7.05 **
CXCL12 moderate 1.50 2.98 **
IFN-c not detected - -
IL-1a moderate 7.37 46.93 **
IL-4 not detected - -
IL-5 moderate 0.97 2.56 **
IL-6 high 0.39 7.80 **
IL-8 moderate 5.08 670.15 **
IL-10 low 1.07 2.00
IL-12p35 moderate 10.69 ** 0.85
IL-13 low 0.93 0.93
IL-17A not detected - -
IL-23p19 high 0.47 1.66
IL-33 not detected - -
MUC1 high 2.21 ** 1.30
MUC2 low 1.46 0.74
MUC4 moderate 0.9 0.77
PBD-1 low 0.5 1.07
PBD-2 not detected - -
PPAR-c high 2.59 ** 1.21
Secretory
component
high 0.66 0.78
TGF-b high 1.64 0.62
TNF-a low 5.12 3075.63 **
TSLP moderate 1.17 1.36
Level of mRNA expressions in untreated cells are expressed in the second
column (high: Amplification around 17–24 cq (cycle quantification), moderate:
Around 25–29 cq, low: Around 30–33 cq, not detected: More than 33 cq).
Asterisks
**denote p,0.01
doi:10.1371/journal.pone.0018573.t002
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effect on E. coli O157:H7 probably through ethanol production
[33], thus highlighting another potential anti-inflammatory effect
used by the yeast. In our study, inhibition of pro-inflammatory
gene expressions was correlated with a decrease of the MAPK
ERK1/2 and p38 phosphorylation. These results are reminiscent
of other studies showing that Sb inhibits IL-8 expression and
MAPK phosphorylation induced by enteric pathogens such as
enterohemorrhagic E. coli [21], Clostridium difficile [20], S. enterica
Serovar Typhimurium [18] and Shigella flexneri [16]. Inhibition of
pro-inflammatory IL-6, CCL20 and CXCL10 transcript expres-
sions could also be associated with the inhibition of ERK1/2 and
p38 MAPK signaling pathways since the activation of these
protein kinases has been shown to correlate with IL-6, CCL20 and
CXCL10 expressions in different cell types [47,48,49,50]. In
contrast, detection level of JNK in untreated and ETEC-exposed
IPEC-1 cells was too low to display any regulatory effect of Sc.W e
also analysed whether or not the inhibition of the pro-
inflammatory responses might be due to a modulation of Akt
and AMPK activity. Previous studies described that Akt and
AMPK are activated during intestinal inflammation [51,52].
Moreover, Sb has been shown to decrease Akt activation in human
HT29 colonocytes [53]. Neither Sc nor ETEC modulated Akt and
AMPK signaling pathways in our model. This result could be
explained by their activation at a different time point. In addition,
Sc and ETEC could stimulate pathogen recognition receptors
which did not activate these protein kinases in IPEC-1 cells. Taken
together, these results show that Sc (strain CNCM I-3856) interfer
with MAPK (ERK1/2, p38) signaling pathways and decrease pro-
inflammatory responses in porcine intestinal epithelial IPEC-1
cells exposed with ETEC. These anti-inflammatory properties are
in accordance with those described with the probiotic yeast Sb
[16,18,20] and indicate that both Sc and Sb can inhibit cell
signaling pathways despite their genetic, metabolic and physiologic
differences [27,28]. Several reports displayed also that Sb decrease
NF-kB activation in IEC infected with enteric pathogens such as
Figure 2. Viable Saccharomyces cerevisiae down-regulates cytokine and chemokine mRNA relative expressions induced by ETEC.
Differentiated IPEC-1 cells were cultured overnight with (A) viable Sc or (B) killed Sc (3610
6 yeasts/well) and then ETEC (3610
7 CFU/well) was added
to the co-culture for 3 h. Gene expression was analysed by RT-qPCR. Data are presented as means 6 SEM (n=6), asterisks denote: ** (P,0.01). (A)
Data are representative of three independent experiments.
doi:10.1371/journal.pone.0018573.g002
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However, Sc effect on NF-kB activation was not assessed in this
study and thus requires further investigations.
In addition, we showed that Sc up-regulated significantly the
mRNA levels of the pro-Th1 cytokine IL-12p35, the chemokine
CCL25 and the nuclear receptor PPAR-c. CCL25 is known to be
involved in T and B cells recruitment into the small intestine
[54,55]. Thus, Sc might stimulate the mucosal immune response
and IgA plasma cell recruitment through enhancement of CCL25
expression. Previous in vivo studies displayed that oral administra-
tion of Sb to mice increases the concentration of intestinal IgA
[17,56]. The up-regulation of CCL25 expression could potentially
explain, at the molecular level, one mechanism used by probiotic
yeasts to stimulate the mucosal immune response. Because IPEC-1
cells express CCL25, we also assessed the expression of Cdx-1 and
-2 transcription factors which has been shown to regulate CCL25
transcription [57]. Our study did not show any Cdx-1 and -2
transcript expressions by IPEC-1 cells. This result is in agreement
with previous studies reporting that Cdx-1 and -2 were not
expressed by immortalized epithelial cell lines [57,58] suggesting
either a different mechanism for CCL25 regulation or an
activation of Cdx-1 and -2 expression at a different time point.
Sc increased the transcript expression of IL-12p35 whereas ETEC
did not. This result is in accordance with previous studies showing
that Sc stimulates the secretion of IL-12p70 in activated human
neutrophil-like 60 cells and monocyte-derived dendritic cells
[59,60]. In contrast, E. coli pathovars such as ETEC failed to
stimulate IL-12p40 expression in bovine primary colonocytes [61].
These results may suggest that Sc and ETEC could influence
differently the immune response in part through modulation of IL-
12 expression level. PPAR-c is a nuclear receptor expressed by
several cell types including IEC, dendritic cells, T and B cells and
acts as a regulator of the inflammation [62,63,64]. In our study we
shown an up-regulation of PPAR-c transcripts and thus Sc could
also mediate anti-inflammatory effects through activation of
PPAR-c. This result could be correlated with previous studies
showing that Sb up-regulated PPAR-c expression in human
colonocytes [65] and that PPAR-c decreased pro-inflammatory
cytokine levels in IEC [66]. Moreover, previous studies showed
that activation of ERK1/2 regulated negatively the expression of
PPAR-c [67,68] suggesting that both Sc stimulatory effects on
PPAR-c expression and inhibitory effects on ERK1/2 activation
could be linked [69].
In this study, we also showed that the number of cell-associated
ETEC is increased in presence of Sc while the number of non cell-
associated ETEC is decreased. Consequently, we hypothesized
that adherent yeasts on IPEC-1 cells could agglutinate ETEC thus
forming agglutinates on the surface monolayer as shown
previously with S. enterica serovar Typhimurium on the surface of
T84 cells [18]. An agglutination of ETEC by Sc was observed by
phase-contrast microscopy in IPEC-1 cell culture supernatant.
This result suggests that the higher number of cell-associated
bacteria observed in presence of Sc might be due to yeast-bacteria
agglutinates on the surface monolayer despite the lack of
confirmation by scanning electron microscopy. Furthermore, the
agglutination of ETEC by yeasts may explain partially the
inhibition of pro-inflammatory gene expressions in IPEC-1 cells
which could be less stimulated by bacterial components such as
LPS or flagellin. We also determined that ETEC decreased
significantly the TER of IPEC-1 cells exposed to ETEC. This
result is in agreement with others reports showing that ETEC
decreased the TER in porcine IPEC-1 and IPEC-J2 cells [70,71]
and altered tight-junction structure in IPEC-1 cells [35]. TER
measurement displayed that Sc failed to preserve the barrier
function of infected IPEC-1 cells despite its anti-inflammatory
activity. This result differed from a previous report showing that
yeast extracts prevent both TER and membrane permeability
decreases induced by ETEC [71]. However, previous studies
Figure 3. Saccharomyces cerevisiae up-regulates CCL25, PPAR-c and IL-12p35 mRNA relative expressions. Differentiated IPEC-1 cells were
cultured overnight with (A) viable Sc or (B) killed Sc (3610
6 yeasts/well) and then ETEC (3610
7 CFU/well) was added to the co-culture for 3 h. Gene
expression was analysed by RT-qPCR. Data are presented as means 6 SEM (n=6), asterisks denote: * (P,0.05), ** (P,0.01). (A) Data are representative
of three independent experiments.
doi:10.1371/journal.pone.0018573.g003
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function [72,73]. Consequently, this result suggests that Sc does not
inhibit ETEC enterotoxin activity leading to the disruption of the
transepithelial resistance.
In conclusion, results demonstrate that Sc (strain CNCM I-
3856) inhibits pro-inflammatory gene expressions. This inhibition
is associated to the modulation of both ERK1/2 and p38
signaling pathways, the increase of PPAR-c transcript expression
and the ETEC agglutination by yeasts. Sc stimulates also the
transcript expression of CCL25 and IL-12p35. These results
indicate that Sc exerts immuno-modulatory effects at the
molecular level in IPEC-1 cells encouraging the assessment of
Sc in vivo modulatory effects in the immune and inflammatory
responses.
Materials and Methods
Epithelial cell line culture
The non-transformed porcine intestinal epithelial cell line
IPEC-1 was derived from the small intestine of a newborn
unsuckled piglet [74]. Cells were cultured in DMEM/F-12
medium (Invitrogen, Cergy Pontoise, France) supplemented with
5% foetal calf serum (Sigma–Aldrich, Saint-Quentin, France),
2 mM L-glutamine (Invitrogen), 1% insulin-transferrin-selenium
(Sigma-Aldrich, Saint-Quentin, France), 10 ng/ml epidermal
growth factor (Invitrogen), 50 U/ml penicillin and 50 mg/ml
streptomycin (Invitrogen). For co-culture experiments, IPEC-1
cells were seeded onto 4.2 cm
2 cell culture inserts (pore size
0.4 mm, Becton Dickinson Labware, Le Pont De Claix, France) at
3.5610
5 cells per inserts. Inserts were not collagen-coated. IPEC-1
cells were grown for 2 days until 100% of confluence and then
differentiated for 10 days. For differentiation culture, the medium
described above was modified with the omission of foetal calf
serum and the addition of 10
-7 M dexamethasone (Sigma–
Aldrich). Differentiation culture medium was changed every 2
days. Once differentiated, IPEC-1 cells had an average cell density
of 1610
6 cells/well and the transepithelial electrical resistance
measured with a Millicell-ERS volt-ohm meter (Millipore,
Molsheim, France) was typically around 8000 ohm.cm
2. Differ-
entiated IPEC-1 cells exhibit apical and basolateral surfaces, form
apical microvilli and express tight junction proteins [35,74].
Microorganisms’ growth
The ETEC strain GIS26 (O149:K91, F4ac
+,L T
+ STa
+ STb
+ :
H19) was grown in Luria-Bertani (LB) medium containing 1%
tryptone, 0.5% yeast extract, 1% NaCl, pH 7. After overnight
incubation at 37uC with vigorous shaking, bacteria were diluted at
1:400 in fresh LB and grown until midlog phase (,4 h) for all
experiments.
Saccharomyces cerevisiae (strain CNCM I-3856, Lesaffre yeast
collection, CNCM: French National deposit Collection of
Microorganism Cultures, Institut Pasteur, Paris, France) were
Figure 4. Saccharomyces cerevisiae decreases IL-6 and IL-8 secretions induced by ETEC. Differentiated IPEC-1 cells were cultured overnight
with (A) viable or (B) killed Sc (3610
6 yeasts/well) and then ETEC (3610
7 CFU/well) was added to the co-culture for 30 min. Differentiated IPEC-1 cells
were then washed and cultured for another 24 h before the assessment of apical IL-6 and IL-8 secretions by ELISA. Data are presented as means of
cytokine concentration 6 SEM (n=3-4), asterisks denote: * (P,0.05), ** (P,0.01). Data are representative of two independent experiments.
doi:10.1371/journal.pone.0018573.g004
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Baroeul, France) as a dry form at a concentration of 1610
10
yeasts/g. Sc was rehydrated in free-DMEM/F-12 medium
(Invitrogen, Cergy Pontoise, France) for 45 min at 30uC. For the
different experiments, concentration of viable Sc was established
by methylene blue exclusion (0.3 g/L methylene blue, 20 g/L
sodium citrate). To evaluate the effects of killed Sc, yeasts were
rehydrated in DMEM/F-12 medium and then frozen in liquid
nitrogen. After ten cycles of freezing/thawing, mortality resulted in
100% of killed yeasts.
Figure 5. Saccharomyces cerevisiae decreases the MAP Kinase (ERK1/2, p38) phosphorylation in differentiated IPEC-1 cells.
Differentiated IPEC-1 cells were exposed for 30 and 60 min with ETEC (3610
7 CFU/well) in the presence and absence of Sc (3610
6 yeasts/well).
Western blots for phospho-ERK1/2 (p-ERK1/2) and phospho-p38 (p-p38) were performed. Total ERK1/2 and total p38 are shown as loading controls
and did not change with each condition over time. Data are presented as means 6 SEM, (n=3) and the different letters represent significant
differences between the treatments (P,0.05). Results are representative of three independent experiments.
doi:10.1371/journal.pone.0018573.g005
Saccharomyces cerevisiae Immuno-Modulatory Effects
PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e18573Antibodies
Immunoblots were performed using the phosphorylated anti-
bodies: (p)-ERK1/2 (4377S, Ozyme, Saint-Quentin-en-Yvelines,
France), p-p38 (9211S, Ozyme), p-JNK 1/2/3 (9251, Ozyme), p-
AMPK (2535L, Ozyme), p-Akt (sc-7985-R, Santa Cruz Biotech-
nology, Heidelberg, Germany), and the total antibodies: ERK2
(sc-154, Santa Cruz Biotechnology, cross-reacts with ERK1), p38
(sc-535, Santa Cruz Biotechnology), JNK (9252, Ozyme), AMPK
(2532L, Ozyme), Akt (9272, Ozyme). According to the manufac-
turers, all antibodies react with human whereas only antibodies
specific for p-ERK1/2, p-p38 and Akt cross-react with pig.
IPEC-1 exposure to ETEC
Prior to exposure, IPEC-1 cells (,1610
6 cells/well) were washed
three times in medium without serum and antibiotics. The ETEC
strain GIS26 was grown for 4 h in LB medium, pelleted by
centrifugation at 2000 g for 20 min, resuspended in sterile phos-
phate-buffered saline and added to IPEC-1 cells at 3610
7 CFU/well
(30 bacteria/cell) for 3 h. When experiments were performed in
presence of Sc, IPEC-1 cells were pre-incubated overnight with 3610
6
yeasts/well (3 yeasts/cell) and then exposed to ETEC for 3 h.
Overnight pre-incubation of IPEC-1 cells with Sc w a sc h o s e ni no r d e r
to assess the yeast preventive effects as described previously [22,23].
Both ETEC and Sc were added to the apical compartment.
Analysis of relative mRNA expression using quantitative
real-time PCR
IPEC-1 cells (,1610
6 cells/well) were incubated overnight with
viable or killed Sc (3610
6 yeasts/well) and then exposed to ETEC
(3610
7 CFU/well) for 3 h. IPEC-1 cells were lyzed with Trizol
reagent (Invitrogen, Cergy-Pontoise, France) and total RNA was
isolated using RNeasy Mini Kit (Qiagen, Courtaboeuf, France).
Figure 6. Saccharomyces cerevisiae agglutinates ETEC. (A) IPEC-1 cells were exposed to ETEC (3610
7 CFU/well) for 30 min in the presence or
absence of Sc (3610
6 yeasts/well). Cells were then lysed and cell lysates were diluted and plated on agar in order to quantify the cell-associated
bacteria, (n=4). (B) IPEC-1 cells were exposed to ETEC (3610
7 CFU/well) for 3 h in the presence or absence of Sc (3610
6 yeasts/well) and 100 mlo f
culture supernatant were then harvested from the apical compartment, diluted and plated on agar in order to quantify the non cell-associated
bacteria, (n=4). (C) IPEC-1 cells were overnight pre-incubated with Sc (3610
6 yeasts/well) and then exposed to ETEC (3610
7 CFU/well) for 3 h. Apical
IPEC-1 cell culture supernatant was harvested and physical interaction between Sc and ETEC was observed by phase contrast microscopy (x 1000).
Data are presented as means 6 SEM, asterisks denote: * (P,0.05), *** (P,0.001). (A, B) Data are representatives of two independent experiments.
doi:10.1371/journal.pone.0018573.g006
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synthesized as previously described [58]. Diluted cDNA (10X) was
combined with primer/probe sets and MESA GREEN qPCR
MasterMix (Eurogentec, Lie `ge, France) according to the manu-
facturer’s recommendations. The qPCR conditions were 95uC for
30 s, followed by 37 cycles with denaturation at 95uC for 15 s and
annealing/elongation for 45 s. To minimize sample variation, we
used high quality RNA. Samples were normalized internally using
simultaneously the average cycle quantification (Cq) of Hypoxan-
thine PhosphoRibosyl-Transferase 1 (HPRT-1), Ribosomal Pro-
tein L 19 (RPL-19) and Hydroxymethylbilane synthase 2
(HMBS2) [75] as references in each sample to avoid any artefact
of variation in the target gene. These reference genes were selected
for their stable expression in IPEC-1 cell line as described
previously [76]. The primer sequences and the annealing
temperatures are described in Table 1. Real time assays were
run on a Bio-Rad Chromo4 (Bio-Rad, Hercules, CA, USA).
Expression data are expressed as relative values after Genex macro
analysis (Bio-Rad, Hercules, CA, USA) [77]. The design of qPCR
experiments and the analysis of results were performed following
the MIQE guidelines [78].
Measurement of apical IL-6 and IL-8 production
IPEC-1 cells (,1610
6 cells/well) were incubated overnight with
viable or killed Sc (3610
6 yeasts/well) and then exposed to ETEC
(3610
7 CFU/well) for 30 min. The time of ETEC exposure was
chosen to avoid a massive alteration of the monolayer after the
subsequent washes. After 3 washes, differentiation culture medium
containing 50 mg/mL of gentamycin (Invitrogen) was added on
IPEC-1 cells for 24 h. Apical and basolateral supernatants were then
removed and cytokine production was measured by ELISA using
commercial kits (R&D for IL-6 assay and Invitrogen for IL-8 assay).
Western Blotting
IPEC-1 cells (,1610
6 cells/well) were incubated overnight with
Sc (3610
6 yeasts/well) and then exposed to ETEC (3610
7 CFU/
well) for 30 and 60 min. Cells were then lysed in TNET lysis
buffer (20 mM Tris pH 7.8, 50 mM NaCl, 5 mM EGTA, 1% (v/
v) Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 4 mM
Na3VO4,5 mg/ml leupeptin, 5 mg/ml pepstatin, and 5 mg/ml
aprotinin). Equal amounts of proteins were separated on SDS-
PAGE and transferred onto a nitrocellulose membrane. Mem-
branes were incubated for 1 h at room temperature with Tris-
buffered saline (TBS, 2 mM Tris–HCl, pH 8.0, 15 mM NaCl,
pH 7.6), containing 5% non fat dry milk powder (NFDMP) and
0.1% Tween-20 to saturate non specific sites. Then, membranes
were incubated overnight at 4uC with appropriate primary
antibodies (final dilution 1:1000) in TBS containing 0.1%
Tween-20 and 5% NFDMP. After washing in TBS–0.1%
Tween-20, the membranes were incubated for 2 h at room
temperature with a HRP-conjugated goat anti-rabbit secondary
antibody (final dilution 1:10000; Diagnostic Pasteur, Marnes-la-
Coquette, France) in TBS–0.1% Tween-20. After washing in
TBS–0.1% Tween-20, the signal was detected by ECL (ECL,
Amersham Pharmacia Biotech, Orsay, France). The films were
analysed and signals quantified with the software Scion Image
(4.0.3.2 version; Scion Corporation, Frederick, MD, USA).
Saccharomyces cerevisiae effects on ETEC adhesion to
IPEC-1 cells
The number of cell-associated ETEC was determined by agar
plating. IPEC-1 cells (,1610
6 cells/well) were infected with
ETEC (3610
7 CFU/well) for 30 min in the presence or absence
of Sc (3610
6 yeasts/well). The time of ETEC exposure was
decreased from 3 h to 30 min to avoid a massive alteration of the
monolayer after the subsequent washes. After 6 washes, cells were
lysed with ultra pure water supplemented with 1%-Triton-X-100.
Cell lysates containing the cell-associated ETEC were diluted and
plated on 5% sheep blood agar. After 20 h of growth at 37uC, the
number of ETEC colony was determined.
The number of non cell-associated ETEC was determined by
agar plating. IPEC-1 cells (,1610
6 cells/well) were infected with
ETEC (3610
7 CFU/well) for 3 h in the presence or absence of Sc
(3610
6 yeasts/well). Then, 100 ml of culture supernatant were
harvested from the apical compartment, diluted and plated on 5%
sheep blood agar. After 20 h of growth at 37uC, the number of
non cell-associated ETEC was quantified.
Scanning electron microscopy and phase contrast
microscopy
For scanning electron microscopy analysis, IPEC-1 cells
(,1610
6 cells/well) were incubated overnight with Sc (3610
6
yeasts/well) and then exposed to ETEC (3610
7 CFU/well) for
45 min. This time was chosen to avoid a massive alteration of the
monolayer induced by the subsequent washes. Then, IPEC-1 cells
were washed 3 times in PBS and then fixed in a mixture of 4%
paraformaldehyde and 1% glutaraldehyde in phosphate buffer
(0.3 M; pH 7.4) for 1 h. IPEC-1 cells were washed with phosphate
buffer pH 7.4 with 0.4% NaCl (w/v) and dehydrated through a
graded series of 50%, 70%, 90% and 100% alcohol solution and
HMDS (hexa-methyl-disilazan). Then, they were let dried and
coated with a thin layer of platinium on a PECS Gatan coater.
Samples were observed on Zeiss Ultra+FEGSEM scanning
electron micrograph (Carl Zeiss S.A.S, Le Pecq, France).
For phase contrast microscopy, IPEC-1 cells (,1610
6 cells/
well) were incubated overnight with Sc (3610
6 yeasts/well) and
then exposed to ETEC (3610
7 CFU/well) for 3 h. The apical cell
culture supernatant was then removed and the interaction
between Sc and ETEC was observed by phase contrast microscopy
(Olympus BX51, Olympus S.A.S, Rungis, France).
Transepithelial electrical resistance measurements
Transepithelial electrical resistance (TER) was measured to
assess the integrity of epithelial monolayers using a Millicell-ERS
volt-ohm meter (Millipore, Molsheim, France). IPEC-1 cells
cultured onto 4.2 cm
2 cell culture inserts were pre-incubated
overnight with Sc (3610
6 yeasts/well) and then exposed to ETEC
Figure 7. Saccharomyces cerevisiae failed to preserve the barrier
function. Measurement of transepithelial electrical resistance (TER) in
differentiated IPEC-1 cells untreated, pre-incubated with Sc (3610
6
yeasts/well), exposed to ETEC (3610
7 CFU/well) or pre-incubated with
Sc and then exposed with ETEC. Data are presented as means 6 SEM,
(n=4). Data are representative of two independent experiments,
asterisks denote: *** (P,0.001).
doi:10.1371/journal.pone.0018573.g007
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7 CFU/well) for 3 h. TER was measured each hour after
ETEC addition.
Statistical analysis
The comparison of the differences in mRNA relative expression
and cytokine production were evaluated by one-way ANOVA and
differences tested by non-parametric Dunnett’s test. (using GraphPad
Prism software version 4.00, GraphPad Software Inc., San Diego,
CA, USA). Differences were considered significant when P,0.05.
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